Orphan designation: methotrexate Treatment of primary large B-cell lymphoma of immune-privileged sites, 22/08/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 April 2026 - 10:13

Orphan designation: methotrexate Treatment of primary large B-cell lymphoma of immune-privileged sites, 22/08/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3135

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters